Recombinant CD52 (Gatralimab Biosimilar) antibody

Catalog No. ABIN7538082

The Humanized Chimeric anti-CD52 (Gatralimab Biosimilar) antibody is suitable to detect CD52 (Gatralimab Biosimilar) in samples from Human. It has been validated for ELISA and WB.

Quick Overview for Recombinant CD52 (Gatralimab Biosimilar) antibody (ABIN7538082)

Target: CD52 (Gatralimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CD52 (Gatralimab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-CD52 (Gatralimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Gatralimab Biosimilar - Anti-CD52 mAb - Research Grade

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CD52 (Gatralimab Biosimilar)

Target: CD52 (Gatralimab Biosimilar)

Target Type: Biosimilar

Background: Gatralimab (GZ-402668) is an IgG1 anti-CD52 monoclonal antibody.

CAS-No: 1826020-80-7